Irving C C, Cox R, Murphy W M
Cancer Lett. 1979 Nov;8(1):3-7. doi: 10.1016/0304-3835(79)90016-8.
N-methyl-N-nitrosourea (MNU) was instilled by a urethral catheter into the urinary bladders of female Wistar rats in weekly doses of 0.5 mg for 1, 2, 3 and 4 weeks. At 75 weeks after the initial dose of MNU, the incidences of bladder cancer were 0, 7, 50 and 64% for the total doses of MNU of 0.5, 1.0, 1.5 and 2.0 mg, respectively. Control rats instilled with 0.9% NaCl only for 1--4 weeks did not develop bladder cancer by 75 weeks. Higher doses of MNU of 4.0 and 6.0 mg, given weekly in 0.5 mg amounts for 8 and 12 weeks, respectively, induced a higher incidence (nearly 90%) of urinary bladder cancer in rats at 22--28 weeks. However, it was shown that control rats given 12 weekly installations of solvent only developed a significant number (33%) of bladder cancers by 22--28 weeks.
通过尿道导管将N-甲基-N-亚硝基脲(MNU)以每周0.5毫克的剂量注入雌性Wistar大鼠的膀胱,持续1、2、3和4周。在首次给予MNU剂量75周后,MNU总剂量分别为0.5、1.0、1.5和2.0毫克时,膀胱癌的发生率分别为0%、7%、50%和64%。仅用0.9%氯化钠灌注1 - 4周的对照大鼠到75周时未发生膀胱癌。分别以每周0.5毫克的剂量给予4.0和6.0毫克的更高剂量MNU,持续8周和12周,在22 - 28周时诱导大鼠膀胱癌的发生率更高(近90%)。然而,结果显示仅给予12周溶剂的对照大鼠在22 - 28周时也出现了相当数量(33%)的膀胱癌。